The economic burden of depression in Switzerland

PharmacoEconomics

Volumn 31, Issue 3, 2013, Pages 237-250

  Tomonaga, Yuki ^a   Haettenschwiler, Josef ^b   Hatzinger, Martin ^c   Holsboer Trachsler, Edith ^d   Rufer, Michael ^e   Hepp, Urs ^f   Szucs, Thomas D ^g  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Center for Anxiety and Depression   (Switzerland)

^c Psychiatric Services Solothurn   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f Outpatient Psychiat Hospital Aargau   (Switzerland)

^g UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COST OF ILLNESS; DEPRESSION; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESOURCE ALLOCATION; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SWITZERLAND;

EID: 84876927733     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.1007/s40273-013-0026-9     Document Type: Article

References (56)

1. World Health Organization. Depression [fact sheet no. 369]. Geneva: WHO; 2012. http://www.who.int/mediacentre/factsheets/fs369/en/index.html. Accessed 16 Jan 2013.
2. American Psychiatric Association. DSM-IV-TR. Arlington: APA; 2012. http://www.psychiatry.org/practice/dsm/dsm-iv-tr. Accessed 16 Jan 2013.
3. World Health Organization. International Classification of Diseases (ICD). http://www.who.int/classifications/icd/en/. Accessed 16 Jan 2013.
4. Pedersen SH, Stage KB, Bertelsen A, et al. ICD-10 criteria for depression in general practice. J Affect Disord. 2001;65(2):191-4. (Pubitemid 32448944)
5. Ajdacic-Gross V, Graf M. Bestandesaufnahme und Daten zur psychiatrischen Epidemiologie - Informationen über die Schweiz. Neuchatel: Schweizerisches Gesundheitsobservatorium; 2003.
6. Schuler D, Rüesch P, Weiss C. Psychische Gesundheit in der Schweiz - Monitoring. Neuchatel: Schweizerisches Gesundheitsobservatorium; 2007.
7. Swiss Federal Statistical Office (FSO). Mortality, causes of death - data, indicators. Deaths: numbers, trends and causes. 2010 [in German]. Neuchâtel: BFS; 2013. http://www.bfs.admin.ch/bfs/portal/de/index/themen/ 14/02/04/key/01.html. Accessed 16 Jan 2013.
8. Arsenault-Lapierre G, Kim C, Turecki G. Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry. 2004;4:37. (Pubitemid 40177132)
9. Swiss Federal Statistical Office (FSO). Nachhaltige Entwicklung - MONET: Lebensbedingungen - Suizidrate. Neuchâtel: BFS; 2013. http://www.bfs. admin.ch/bfs/portal/de/index/themen/21/02/ind32.indicator.70301.3201.html. Accessed 17 Jan 2013.
10. Eurostat. Death due to suicide, by sex: standardised death rate by 100 000. Inhabitants. Luxembourg: European Commission, Eurostat; 2012. http://epp.eurostat.ec.europa.eu/tgm/refreshTableAction.do?tab=table&plugin= 0&pcode=tps00122&language=en. Accessed 17 Jan 2013.
11. Swiss Federal Statistical Office (FSO), Ärztliche Behandlung: Depression. Schweizerische Gesundheitsbefragung. http://www.bfs.admin.ch/bfs/ portal/de/index/themen/14/02/01/key/02.html. Accessed 16 Jan 2013.
12. Swiss Federal Office of Public Health (FOPH), Nationale Gesundheitspolitik Schweiz (NGP), Psychische Gesundheit - Strategieentwurf zum Schutz, zur Förderung, Erhaltung und Wiederherstellung der psychischen Gesundheit der Bevölkerung in der Schweiz. Bern: BAG; 2004. http://www.bag.admin.ch/themen/medizin/00683/01916/. Accessed 16 Jan 2013.
13. Beeler I, Lorenz S, Szucs TD. Provision and remuneration of psychotherapeutic services in Switzerland. Sozial und Praventivmedizin. 2003;48(2):88-96. (Pubitemid 36700634)
14. Gabriel P, Liimatainen M. Mental health in the workplace. Geneva: International Labour Organization; 2000.
15. Lachenmeier H. Mental health - Ein Wirtschaftsfaktor. Neue Zürcher Zeitung. 6. Febr. 2003, Nr. 30, p. 14. http://www.synapse-online.ch/uploads/ media/2003-3.pdf. Accessed 16 Jan 2013.
16. Andlin-Sobocki P, Jonsson B, Wittchen HU, et al. Cost of disorders of the brain in Europe. Eur J Neurol. 2005;12(Suppl 1):1-27.
17. Jäger M, Sobocki P, Rossler W. Cost of disorders of the brain in Switzerland with a focus on mental disorders. Swiss Med Wkly. 2008;138(1-2):4-11. (Pubitemid 351171089)
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
19. Williams JB. A structured interview guide for the Hamilton Depression Rating Scale. Arch General Psychiatry. 1988;45(8):742-7.
20. Hamilton M. Hamilton Depression Rating Scale (17-item version). Castres: NeuroBiz Consulting; 2008. http://www.psy-world.com/hdrs.htm. Accessed 17 Jan 2013.
21. Aina Y, Susman JL. Understanding comorbidity with depression and anxiety disorders. J Am Osteopathic Assoc. 2006;106(5 Suppl 2):S9-14.
22. Montgomery SA, Kasper S. Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine. Int Clin Psychopharmacol. 2007;22(5):283-91. (Pubitemid 47237547)
23. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905-17. (Pubitemid 44807782)
24. Swiss Federal Social Insurance Office (FSIO). IV-Statistik 2008. Bern: BSV; 2007. http://www.bsv.admin.ch/dokumentation/zahlen/00095/00442/01378/index. html?lang=de. Accessed 17 Jan 2013.
25. Swiss Federal Statistical Office (FSO), Krankenhausstatistik und Statistik der sozialmedizinischen Institutionen 2005. Neuchâtel: BFS; 2007. http://www.bfs.admin.ch/bfs/portal/de/index/news/publikationen.html? publicationID=2601. Accessed 18 Jan 2013.
26. Sturny I, Schuler D, Camenzind P. Psychiatrische und psychotherapeutische Versorgung in der Schweiz - Monitoring 2008. Neuchatel: Schweizerisches Gesundheitsobservatorium, Obsan; 2009.
27. Swiss Drug Compendium 2009. Basel: Documed AG, Mohn Media - Mohndruck GmbH; 2009. http://www.kompendium.ch/home/prof/de. Accessed 1 Dec 2009.
28. Eaton WW, Shao H, Nestadt G, et al. Population-based study of first onset and chronicity in major depressive disorder. Arch General Psychiatry. 2008;65(5):513-20. (Pubitemid 351645047)
29. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-105. (Pubitemid 37432885)
30. Birnbaum HG, Kessler RC, Kelley D, et al. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depression Anxiety. 2009;27(1):78-89.
31. Swiss Federal Statistical Office (FSO). Arbeitslosigkeit in der Schweiz 2009, Staatssekretariat für Wirtschaft SECO. Neuchâtel: BFS; 2010. http://www.bfs.admin.ch/bfs/portal/de/index/themen/03/22/publ.html? publicationID=4006. Accessed 18 Jan 2013.
32. Swiss Federal Social Insurance Office (FSIO). IV-Statistik Dezember 2009. Bern: BVS; 2009. http://www.bsv.admin.ch/dokumentation/zahlen/00095/00442/ index.html?lang=de. Accessed 12 Jan 2009.
33. Swiss Federal Statistical Office (FSO), Arbeitsvolumenstatistik (AVOL). Wöchentliche Normalarbeitszeit der Vollzeitarbeitnehmenden nach Geschlecht, Nationalität und Wirtschaftsabschnitten 1991-2011. / Jährliche Dauer der Absenzen und Absenzenquote der Vollzeitarbeitnehmenden nach Geschlecht, Nationalität und Wirtschaftsabschnitten 1991-2011. Neuchâtel: BFS; 2013. http://www.bfs.admin.ch/bfs/portal/de/index/themen/03/02/blank/data/06. html. Accessed 21 Jan 2013.
34. Johnston K, Westerfield W, Momin S, et al. The direct and indirect costs of employee depression, anxiety, and emotional disorders - an employer case study. J Occup Environ Med. 2009;51(5):564-77.
35. Angst J, Gamma A, Rossler W, et al. Long-term depression versus episodic major depression: results from the prospective Zurich study of a community sample. J Affect Disorders. 2009;115(1-2):112-21.
36. Cuijpers P, Smit F, Oostenbrink J, et al. Economic costs of minor depression: a population-based study. Acta Psychiatrica Scandinavica. 2007;115(3):229-36.
37. Kessler RC, Walters EE. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depression Anxiety. 1998;7(1):3-14. (Pubitemid 28248515)
38. Screening and treatment for major depressive disorder in children and adolescents. US Preventive Services Task Force Recommendation Statement. Pediatrics. 2009;123(4):1223-8.
39. Rohde P, Beevers CG, Stice E, et al. Major and minor depression in female adolescents: onset, course, symptom presentation, and demographic associations. J Clin Psychol. 2009;65(12):1339-49.
40. Williams SB, O'Connor EA, Eder M, et al. Screening for child and adolescent depression in primary care settings: a systematic evidence review for the US Preventive Services Task Force. Pediatrics. 2009;123(4):e716-35.
41. Djernes JK. Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatrica Scandinavica. 2006;113(5):372-87.
42. Gostynski M, Ajdacic-Gross V, Gutzwiller F, et al. Depression among the elderly in Switzerland. Der Nervenarzt. 2002;73(9):851-60. (Pubitemid 36062321)
43. Weyerer S, Eifflaender-Gorfer S, Kohler L, et al. Prevalence and risk factors for depression in non-demented primary care attenders aged 75 years and older. J Affect Disorders. 2008;111(2-3):153-63.
44. Luppa M, Heinrich S, Matschinger H, et al. Direct costs associated with depression in old age in Germany. J Affect Disorders. 2008;105(1-3):195-204. (Pubitemid 350236364)
45. Katon WJ, Lin E, Russo J, et al. Increased medical costs of a population-based sample of depressed elderly patients. Arch General Psychiatry. 2003;60(9):897-903. (Pubitemid 37122308)
46. Kessler R, White LA, Birnbaum H, et al. Comparative and interactive effects of depression relative to other health problems on work performance in the workforce of a large employer. J Occup Environ Med. 2008;50(7):809-16.
47. Mendlewicz J. Sleep disturbances: core symptoms of major depressive disorder rather than associated or comorbid disorders. World J Biol Psychiatry. 2009;10(4):269-75.
48. Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Arch General Psychiatry. 2003;60(1):39-47. (Pubitemid 36070863)
49. Curran GM, Sullivan G, Williams K, et al. The association of psychiatric comorbidity and use of the emergency department among persons with substance use disorders: an observational cohort study. BMC Emerg Med. 2008;8:17.
50. Kunik ME, Snow AL, Molinari VA, et al. Health care utilization in dementia patients with psychiatric comorbidity. Gerontologist. 2003;43(1):86-91. (Pubitemid 36222697)
51. Rutledge T, Vaccarino V, Johnson BD, et al. Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study. J Am Coll Cardiol. 2009;53(2):176-83.
52. Sayers SL, Hanrahan N, Kutney A, et al. Psychiatric comorbidity and greater hospitalization risk, longer length of stay, and higher hospitalization costs in older adults with heart failure. J Am Geriatrics Soc. 2007;55(10):1585-91. (Pubitemid 47508502)
53. Le TK, Able SL, Lage MJ. Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression. Cost Eff Resour Alloc. 2006;4:18. (Pubitemid 44650763)
54. Egede LE, Ellis C. Diabetes and depression: global perspectives. Diabetes Res Clin Pract. 2010;87(3):302-12.
55. Swiss Federal Statistical Office (FSO). Von Generation zu Generation - Entwicklung der Todesursachen 1970 bis 2004. Neuchâtel: BFS; 2008. http://www.bfs.admin.ch.
56. Swiss Federal Statistical Office (FSO). Kosten des Gesundheitswesens nach Leistungserbringern 1995-2010. Neuchâtel: BFS; 2013. http://www.bfs. admin.ch/bfs/portal/de/index/themen/14/05/blank/key/leistungserbringer.html. Accessed 21 Jan 2013.